Related Experiment Video
Updated: May 10, 2025

Herbal Munziq Ameliorates Myocardial Ischemia-Reperfusion Injury by Inhibiting Inflammation
Published on: January 10, 2025
Management of Mirizzi Syndrome Type I: A Case Report
Shirly S1, Mathesh A1, Suismitha S1
1Department of Pharmacy Practice, C.L. Baid Metha College of Pharmacy, Chennai, IND.
Abstract:
Mirizzi syndrome is a rare yet clinically significant condition characterized by mechanical obstruction of the common bile duct (CBD) and the hepatic duct. This obstruction arises from external compression caused by one or more impacted gallstones, most often lodged in Hartmann's pouch, a segment of the gallbladder located near the cystic duct. The prolonged presence of these gallstones can lead to localized inflammation, fibrosis, and scarring, further exacerbating the narrowing of the bile ducts. This condition often presents with symptoms resembling other biliary disorders, making its diagnosis challenging. This report presents a rare case of Mirizzi syndrome Type I in a 64-year-old male patient. The patient was admitted with complaints of right upper quadrant pain for the past two days, radiating to the back, epigastric region, and left hypochondrium. A comprehensive diagnostic evaluation, including magnetic resonance cholangiopancreatography (MRCP) and endoscopic retrograde cholangiopancreatography (ERCP), confirmed the diagnosis of Mirizzi syndrome Type I. The patient underwent ERCP with precut sphincterotomy, biliary plastic stent placement, and cholecystectomy.
More Related Videos
Related Concept Videos
Cystic Fibrosis: Management
Sinus disease and chronic...
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
Irritable Bowel Syndrome III: Medical and Nursing Management
Angle Closure Glaucoma: Treatment
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Chronic Pancreatitis II: Collaborative Care
Assessment:

